Species Diversity and Antifungal Susceptibilities of Oral Yeasts from Patients with Head and Neck Cancer

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.2159031912902
   PubMed Web of Science ®Google Scholar
• Johnson NW, Warnakulasuriya S, Gupta PC, et al. Global oral health inequalities in incidence and outcomes for oral cancer causes and solutions. Adv Dent Res. 2011;23(2):237–246. doi:10.1177/002203451140208221490236
   PubMedGoogle Scholar
• Casiglia J, Woo SB. A comprehensive review of oral cancer. Gen Dent. 2001;49(1):72–82.12004680
   PubMedGoogle Scholar
• Mushi MF, Bader O, Taverne-Ghadwal L, Bii C, Gro U, Mshana SE. Oral candidiasis among African human immunodeficiency virus-infected individuals: 10 years of systematic review and meta-analysis from Sub-Saharan Africa. J Oral Microbiol. 2017;9(1):1317579. doi:10.1080/20002297.2017.131757928748027
   PubMed Web of Science ®Google Scholar
• Kullberg BJ, Arendrup MC, Campion EW. Invasive candidiasis. N Engl J Med. 2015;373(15):1445–1456. doi:10.1056/NEJMra131539926444731
   PubMed Web of Science ®Google Scholar
• Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198–1208. doi:10.1056/NEJMoa130680124670166
   PubMed Web of Science ®Google Scholar
• McCarty TP, Pappas PG. Invasive candidiasis. Infect Dis Clin North Am. 2016;30(1):103–124. doi:10.1016/j.idc.2015.10.01326739610
   PubMed Web of Science ®Google Scholar
• Pappas PG, Rex JH, Lee J, et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis. 2003;37(5):634–643. doi:10.1086/37690612942393
   PubMed Web of Science ®Google Scholar
• Nami S, Mohammadi R, Vakili M, Khezripour K, Mirzael H, Morovati H. Fungal vaccines, mechanism of actions and immunology: a comprehensive review. Biomed Pharm. 2018;109:333–344. doi:10.1016/j.biopha.2018.10.075
   Web of Science ®Google Scholar
• Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309–317. doi:10.1086/42194615306996
   PubMed Web of Science ®Google Scholar
• Cleveland AA, Harrison LH, Farley MM, et al. Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008–2013: results from population-based surveillance. PLoS One. 2015;10(3):e0120452. doi:10.1371/journal.pone.012045225822249
   PubMed Web of Science ®Google Scholar
• Nelson KE, Madupu R, Szpakowski S, Goll JB, Krampis K, Methe BA. Next-generation sequencing, metagenomes, and the human microbiome. In: Xu J, editor. Next-Generation Sequencing: Current Technologies and Applications. Norfolk: Caister Academic Press; 2014:141–155.
   Google Scholar
• Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4(165):165rv13. doi:10.1126/scitranslmed.3004404
   PubMed Web of Science ®Google Scholar
• Pristov KE, Ghannoum MA. Resistance of Candida to azoles and echinocandins worldwide. Clin Microbiol Infect. 2019;25(7):792–798. doi:10.1016/j.cmi.2019.03.02830965100
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20(1):133–163. doi:10.1128/CMR.00029-0617223626
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Moet GJ, Meser SA, Jones RN, Castanheira M. Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY antimicrobial surveillance program, 2008–2009. Antimicrob Agents Chemother. 2011;55(2):561–566. doi:10.1128/AAC.01079-1021115790
   PubMed Web of Science ®Google Scholar
• Wang H, Xu YC, Hsueh PR. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region. Future Microbiol. 2016;11(11):1461–1477. doi:10.2217/fmb-2016-009927750452
   PubMed Web of Science ®Google Scholar
• Rodloff AC, Koch D, Schaumann R. Epidemiology and antifungal resistance in invasive candidiasis. Eur J Med Res. 2011;16(4):187–195. doi:10.1186/2047-783X-16-4-18721486733
   PubMed Web of Science ®Google Scholar
• Wu J, Guo H, Yi G, et al. Prevalent drug resistance among oral yeasts from asymptomatic patients in Hainan, China. Mycopathologia. 2014;177(5–6):299–307. doi:10.1007/s11046-014-9747-324816793
   PubMed Web of Science ®Google Scholar
• Wang H, Xu J, Guo H, et al. Patterns of human oral yeast species distribution on Hainan Island in China. Mycopathologia. 2013;176(5–6):359–368. doi:10.1007/s11046-013-9703-724085613
   PubMed Web of Science ®Google Scholar
• Xu J, Mitchell TG, Vilgalys R. PCR–restriction fragment length polymorphism (RFLP) analyses reveal both extensive clonality and local genetic differences in Candida albicans. Mol Ecol. 1999;8(1):59–73. doi:10.1046/j.1365-294X.1999.00523.x9919698
   PubMed Web of Science ®Google Scholar
• Schoch CL, Seifert KA, Huhndorf S; The Fungal Barcode Consortium. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi. Proc Natl Acad Sci USA. 2012;109(16):6241–6246. doi:10.1073/pnas.111701810922454494
   PubMed Web of Science ®Google Scholar
• Luo C, Feng L, Dai HZ. Application of antifungal agents in 6 cities along the Yangzi River from 2005 to 2007. Chin J New Drugs Clin Remedies. 2009;10:785–790.
   Google Scholar
• Li J. Analysis for usage of antifungal drugs from outpatient pharmacy. Strait Pharm J. 2012;24:258–259.
   Google Scholar
• CLSI. Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts. Approved Guideline. 2nd ed. CLSI document M44-A2. Wayne, PA, USA; Clinical and Laboratory Standards Institute; 2009.
   Google Scholar
• Anonymous. NEO-SENSITABS User’s Guide in Antifungal Susceptibility Testing of Yeast. Taastrup, Denmark: A/S Rosco Diagnostica; 2011.
   Google Scholar
• Wu JY, Guo H, Wang HM, et al. Multilocus sequence analyses reveal extensive diversity and multiple origins of fluconazole resistance in Candida tropicalis from tropical China. Sci Rep. 2017;7(1):42537. doi:10.1038/srep4253728186162
   PubMed Web of Science ®Google Scholar
• Sokal RR, Rohlf FJ. Biometry: The Principles and Practices of Statistics in Biological Research. 2nd ed. New York: Freeman and Company; 1981.
   Google Scholar
• Hämäläinen P, Meurman JH, Kauppinen M, Marja K. Oral infections as predictors of mortality. Gerodontology. 2010;22:151–157. doi:10.1111/j.1741-2358.2005.00064.x
   Google Scholar
• Guo F, Yang Y, Kang Y, et al. Invasive candidiasis in intensive care units in China: a Multicentre Prospective Observational Study. J Antimicrob Chemother. 2013;68(7):1660–1668. doi:10.1093/jac/dkt08323543609
   PubMed Web of Science ®Google Scholar
• Meurman JH, Bascones-Martinez A. Are oral and dental diseases linked to cancer? Oral Dis. 2011;17(8):779–784. doi:10.1111/j.1601-0825.2011.01837.x21819493
   PubMed Web of Science ®Google Scholar
• Nørgaard M, Thomsen RW, Farkas DK, Mogensen MF, Sørensen HT. Candida infection and cancer risk: a Danish Nationwide Cohort Study. Eur J Intern Med. 2013;24(5):451–455. doi:10.1016/j.ejim.2013.02.01723522963
   PubMed Web of Science ®Google Scholar
• Viscoli C, Girmenia C, Marinus A, et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis. 1999;28(5):1071–1079. doi:10.1086/51473110452637
   PubMed Web of Science ®Google Scholar
• Arrua JM, Rodrigues LA, Pereira FO, Lima EO. Prevalence of Candida tropicalis and Candida krusei in onychomycosis in João Pessoa,Paraiba, Brazil from 1999 to 2010. An Acad Bras Cienc. 2015;87(3):1819–1822. doi:10.1590/0001-376520152013041826375021
   PubMed Web of Science ®Google Scholar
• Kumar A. A fungus among us: the emerging opportunistic pathogen Candida tropicalis and PKA signaling. Virulence. 2018;9(1):659–661. doi:10.1080/21505594.2018.143802629436900
   PubMed Web of Science ®Google Scholar
• Douglass AP, Offei B, Braun-Galleani S, et al. Population genomics shows no distinction between pathogenic Candida krusei and environmental Pichia kudriavzevii: one species, four names. PLoS Pathog. 2018;14(7):e1007138. doi:10.1371/journal.ppat.100713830024981
   PubMed Web of Science ®Google Scholar
• Yamada Y, Suzuki T, Matsuda M, Mikata K. The phylogeny of Yamadazyma ohmeri (ETCHELLS et BELL) BILLON-GRAND based on the partial sequences of 18S and 26S ribosomal RNAs: the proposal of Kodamaea gen. nov. (Saccharomycetaceae). Biosci Biotechnol Biochem. 1995;59(6):1172–1174. doi:10.1271/bbb.59.11727613010
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Rudramurthy SM, Kale P, et al. Epidemiological study of a large cluster of fungaemia cases due to Kodamaea ohmeri in an Indian tertiary care centre. Clin Microbiol Infect. 2014;20(2):O83–9. doi:10.1111/1469-0691.1233724004250
   PubMed Web of Science ®Google Scholar
• Das K, Bhattacharyya A, Chandy M, et al. Infection control challenges of infrequent and rare fungal pathogens: lessons from disseminated Fusarium and Kodamaea ohmeri infections. Infect Control Hosp Epidemiol. 2015;36(7):866–868. doi:10.1017/ice.2015.10325998614
   PubMed Web of Science ®Google Scholar
• Paul S, Kannan I. Molecular identification and antifungal susceptibility pattern of Candida species isolated from HIV infected patients with candisiasis. Curr Med Mycol. 2019;5(1):21–26. doi:10.18502/cmm.5.1.53331049454
   PubMedGoogle Scholar
• Ioannou P, Papakitsou I. Kodamaea ohmeri infections in humans: a systematic review. Mycoses. 2020;63(7):636–643. doi:10.1111/myc.1309432323385
   PubMed Web of Science ®Google Scholar
• Paramythiotou E, Frantzeskaki F, Flevari A, Armaganidis A, Dimopoulos G. Invasive fungal infections in the ICU: how to approach, how to treat. Molecules. 2014;19(1):1085–1119. doi:10.3390/molecules1901108524445340
   PubMed Web of Science ®Google Scholar
• Harrington R, Kindermann SL, Hou Q, Taylor RJ, Azie N, Horn DL. Candidemia and invasive candidiasis among hospitalized neonates and pediatric patients. Curr Med Res Opin. 2017;33(10):1803–1812. doi:10.1080/03007995.2017.135482428699797
   PubMed Web of Science ®Google Scholar
• Tóth R, Nosek J, Mora-Montes HM, et al. Candida parapsilosis: from genes to the bedside. Clin Microbiol Rev. 2019;32(2):e00111–18. doi:10.1128/CMR.00111-1830814115
   PubMed Web of Science ®Google Scholar
• Kurtzman CP, Smiley MJ. Heterothallism in Pichia kudriavzevii and Pichia terricola. Antonie Van Leeuwenhoek. 1976;42(3):355–363. doi:10.1007/BF03941351086649
   PubMed Web of Science ®Google Scholar
• Padovan ACB, Rocha WPDS, Toti ACM, Freitas de Jesus DF, Chaves GM, Colombo AL. Exploring the resistance mechanisms in Trichosporon asahii: triazoles as the last defense for invasive trichosporonosis. Fungal Genet Biol. 2019;133:103267. doi:10.1016/j.fgb.2019.10326731513917
   PubMed Web of Science ®Google Scholar
• Pérez-Hansen A, Lass-Flörl C, Lackner M; Rare Yeast Study Group. Antifungal susceptibility profiles of rare ascomycetous yeasts. J Antimicrob Chemother. 2019;74(9):2649–2656. doi:10.1093/jac/dkz23131203366
   PubMed Web of Science ®Google Scholar
• Jahanshiri Z, Manifar S, Moosa H, et al. Oropharyngeal candidiasis in head and neck cancer patients in Iran: species identification, antifungal susceptibility and pathogenic characterization. J Mycol Med. 2018;28(2):361–366. doi:10.1016/j.mycmed.2018.01.00129602636
   PubMed Web of Science ®Google Scholar
• Wu CJ, Lee HC, Yang YL, et al. Oropharyngeal yeast colonization in HIV-infected outpatients in southern Taiwan: CD4 count, efavirenz therapy and intravenous drug use matter. Clin Microbiol Infect. 2012;18(5):485–590. doi:10.1111/j.1469-0691.2011.03655.x21939471
   PubMed Web of Science ®Google Scholar
• Bensadoun RJ, Patton LL, Lalla RV, Epstein JB. Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011. Support Care Cancer. 2011;19(6):737–744. doi:10.1007/s00520-011-1154-421479787
   PubMed Web of Science ®Google Scholar
• Suryawanshi H, Ganvir SM, Hazarey VK, Wanjare VS. Oropharyngeal candidosis relative frequency in radiotherapy patient for head and neck cancer. J Oral Maxillofac Pathol. 2012;16(1):31–37. doi:10.4103/0973-029X.9297022438640
   PubMedGoogle Scholar